Effect of Prebiotic Sodas on Postprandial Levels of GLP-1, PYY, Transit Time and Satiety Levels: A Pilot Study

Exclusion Criteria11

• Self-reported pregnant or breastfeeding women.
• Subjects with a history of severe food allergies or an allergy to acetaminophen.
• Known history of diabetes, any gastrointestinal disorder that alters the absorption of nutrients, liver disease, or the presence of any health condition, illness or drug use that increases risk to the subject or to others or may affect the results, as judged by the Qualified Investigator (QI).
• Subjects who are currently or in the last 2 months have been on oral or injectable GLP-1 receptor agonist (RA) medications.
• Subjects who consume more than 14 alcoholic drinks per week, or more than 5 alcoholic drinks on any one occasion.
• Subjects who have been on antibiotic therapy in the last 2 months.
• Subjects taking the blood thinning drug warfarin.
• Subjects who are habitual users of the following supplements in the past 30 days: berberine, curcumin, cinnamon, resveratrol, and gardenia.
• Subjects which have undergone major surgery in the last 3 months.
• Unwillingness or inability to comply with experimental procedures and to follow Inquis safety guidelines.
• Subject is currently participating or recently (within 30 days of screening) participated in a clinical trial involving long-term exposure (greater than 24 hours) to an investigational drug, nutritional supplement, or lifestyle modification.